These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11316765)

  • 1. Inhibition of growth and increased expression of insulin-like growth factor-binding protein-3 (IGFBP-3) and -6 in prostate cancer cells stably transfected with antisense IGFBP-4 complementary deoxyribonucleic acid.
    Drivdahl RH; Sprenger C; Trimm K; Plymate SR
    Endocrinology; 2001 May; 142(5):1990-8. PubMed ID: 11316765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of an inhibitory insulin-like growth factor binding protein (IGFBP), IGFBP-4, delays onset of prostate tumor formation.
    Damon SE; Maddison L; Ware JL; Plymate SR
    Endocrinology; 1998 Aug; 139(8):3456-64. PubMed ID: 9681496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer.
    Sprenger CC; Damon SE; Hwa V; Rosenfeld RG; Plymate SR
    Cancer Res; 1999 May; 59(10):2370-5. PubMed ID: 10344746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo.
    Devi GR; Sprenger CC; Plymate SR; Rosenfeld RG
    Prostate; 2002 May; 51(2):141-52. PubMed ID: 11948969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer.
    Mutaguchi K; Yasumoto H; Mita K; Matsubara A; Shiina H; Igawa M; Dahiya R; Usui T
    Cancer Res; 2003 Nov; 63(22):7717-23. PubMed ID: 14633696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered growth and insulin-like growth factor-binding protein-3 production in PC3 prostate carcinoma cells stably transfected with a constitutively active androgen receptor complementary deoxyribonucleic acid.
    Marcelli M; Haidacher SJ; Plymate SR; Birnbaum RS
    Endocrinology; 1995 Mar; 136(3):1040-8. PubMed ID: 7532576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.
    Miyake H; Pollak M; Gleave ME
    Cancer Res; 2000 Jun; 60(11):3058-64. PubMed ID: 10850457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
    Miyake H; Nelson C; Rennie PS; Gleave ME
    Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of insulin-like growth factor binding protein-3 by apigenin leads to growth inhibition and apoptosis of 22Rv1 xenograft in athymic nude mice.
    Shukla S; Mishra A; Fu P; MacLennan GT; Resnick MI; Gupta S
    FASEB J; 2005 Dec; 19(14):2042-4. PubMed ID: 16230333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by Mac25/insulin-like growth factor binding-protein-related protein-1.
    Plymate SR; Haugk KH; Sprenger CC; Nelson PS; Tennant MK; Zhang Y; Oberley LW; Zhong W; Drivdahl R; Oberley TD
    Oncogene; 2003 Feb; 22(7):1024-34. PubMed ID: 12592389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect on the insulin-like growth factor system in human prostate epithelial cells of immortalization and transformation by simian virus-40 T antigen.
    Plymate SR; Tennant M; Birnbaum RS; Thrasher JB; Chatta G; Ware JL
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3709-16. PubMed ID: 8855827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
    Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
    Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-binding protein (IGFBP)-1, -2, -3, -4, -5, and -6 and IGFBP-related protein 1 during rainbow trout postvitellogenesis and oocyte maturation: molecular characterization, expression profiles, and hormonal regulation.
    Kamangar BB; Gabillard JC; Bobe J
    Endocrinology; 2006 May; 147(5):2399-410. PubMed ID: 16439447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Episomal expression of sense and antisense insulin-like growth factor (IGF)-binding protein-4 complementary DNA alters the mitogenic response of a human colon cancer cell line (HT-29) by mechanisms that are independent of and dependent upon IGF-I.
    Singh P; Dai B; Dhruva B; Widen SG
    Cancer Res; 1994 Dec; 54(24):6563-70. PubMed ID: 7527300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells.
    Stewart LV; Weigel NL
    Prostate; 2005 Jun; 64(1):9-19. PubMed ID: 15651061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I (IGF-I) regulates IGFBP-3 and IGFBP-4 by multiple mechanisms in A549 human adenocarcinoma cells.
    Price WA; Moats-Staats BM; Stiles AD
    Am J Respir Cell Mol Biol; 1995 Oct; 13(4):466-76. PubMed ID: 7546777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium.
    López-Bermejo A; Buckway CK; Devi GR; Hwa V; Plymate SR; Oh Y; Rosenfeld RG
    Endocrinology; 2000 Nov; 141(11):4072-80. PubMed ID: 11089538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor (IGF) binding protein-3 attenuates prostate tumor growth by IGF-dependent and IGF-independent mechanisms.
    Silha JV; Sheppard PC; Mishra S; Gui Y; Schwartz J; Dodd JG; Murphy LJ
    Endocrinology; 2006 May; 147(5):2112-21. PubMed ID: 16469805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.
    Grzmil M; Hemmerlein B; Thelen P; Schweyer S; Burfeind P
    J Pathol; 2004 Jan; 202(1):50-9. PubMed ID: 14694521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
    Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
    Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.